Cantor Fitzgerald assumed coverage on shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage issued an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Bicara Therapeutics’ FY2024 earnings at ($1.61) EPS. Several other research analysts also recently commented on […]

StockNews.com assumed coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald boosted their target price on Vanda Pharmaceuticals from $11.00 to $13.00 and gave the company an overweight rating in a research note […]

StockNews.com initiated coverage on shares of Beasley Broadcast Group (NASDAQ:BBGI – Free Report) in a report issued on Wednesday. The firm issued a hold rating on the stock. Beasley Broadcast Group Price Performance Shares of BBGI stock opened at $12.72 on Wednesday. The firm has a market cap of $385.98 million, a price-to-earnings ratio of […]

Eli Lilly and Company (NYSE:LLY – Free Report) had its target price raised by Truist Financial from $1,000.00 to $1,033.00 in a report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. LLY has been the subject of a number of other research reports. Morgan Stanley restated an […]

Stock analysts at KeyCorp initiated coverage on shares of Acadia Healthcare (NASDAQ:ACHC – Get Free Report) in a research note issued on Friday, Briefing.com reports. The brokerage set a “sector weight” rating on the stock. ACHC has been the subject of several other research reports. Royal Bank of Canada reiterated an “outperform” rating and set […]

B. Riley reissued their buy rating on shares of Novavax (NASDAQ:NVAX – Free Report) in a report published on Thursday, Benzinga reports. They currently have a $26.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $23.00. Several other equities analysts also recently commented on the company. JPMorgan Chase & […]

HC Wainwright restated their buy rating on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research report report published on Tuesday, Benzinga reports. HC Wainwright currently has a $10.00 price target on the biopharmaceutical company’s stock. Several other analysts also recently commented on RGLS. Canaccord Genuity Group raised their price objective on shares […]

DA Davidson restated their buy rating on shares of SunOpta (NASDAQ:STKL – Free Report) (TSE:SOY) in a research report report published on Thursday, Benzinga reports. DA Davidson currently has a $9.00 price objective on the stock. Separately, StockNews.com upgraded SunOpta from a sell rating to a hold rating in a research report on Thursday. Read […]

StockNews.com upgraded shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) from a hold rating to a buy rating in a research report report published on Monday morning. Several other research firms have also weighed in on FOLD. Jefferies Financial Group assumed coverage on shares of Amicus Therapeutics in a research note on Friday, September 6th. […]

Edwards Lifesciences (NYSE:EW – Free Report) had its price target decreased by Canaccord Genuity Group from $77.00 to $66.00 in a research report report published on Monday, Benzinga reports. Canaccord Genuity Group currently has a hold rating on the medical research company’s stock. Several other brokerages also recently weighed in on EW. Daiwa Capital Markets […]

Piper Sandler reissued their overweight rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research note released on Tuesday, Benzinga reports. Piper Sandler currently has a $62.00 price target on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. Royal Bank of Canada restated an outperform […]

StockNews.com downgraded shares of Amkor Technology (NASDAQ:AMKR – Free Report) from a buy rating to a hold rating in a research report report published on Monday morning. A number of other research firms have also recently weighed in on AMKR. KeyCorp initiated coverage on shares of Amkor Technology in a research note on Friday, September […]

Calix (NYSE:CALX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. A number of other analysts also recently weighed in on CALX. Craig Hallum lifted their price target on Calix from $41.00 to $50.00 and gave the company a […]

StockNews.com downgraded shares of Laboratory Co. of America (NYSE:LH – Free Report) from a buy rating to a hold rating in a report released on Monday morning. A number of other brokerages have also commented on LH. Piper Sandler began coverage on shares of Laboratory Co. of America in a research report on Tuesday, October […]

Mesa Laboratories (NASDAQ:MLAB – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other equities research analysts have also recently issued reports on MLAB. Wells Fargo & Company initiated coverage on Mesa Laboratories in a research note on […]

Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday. VCEL has been the subject of several other reports. TD Cowen increased their target price on Vericel from $55.00 to $60.00 and gave the company a “buy” rating in a research […]